Rotator Cuff Tear Clinical Trial
— ARCR_PredOfficial title:
Surgical Safety and Effectiveness in Orthopedics: Swiss-wide Multicenter Evaluation and Prediction of Core Outcomes in Arthroscopic Rotator Cuff Reconstruction
Verified date | April 2024 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Surgical safety and effectiveness in orthopedics: Swiss-wide multicenter evaluation and prediction of core outcomes in arthroscopic rotator cuff reconstruction.
Status | Active, not recruiting |
Enrollment | 973 |
Est. completion date | September 2024 |
Est. primary completion date | December 21, 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - adult patients - diagnosed with a partial or full-thickness rotator cuff tear using magnetic resonance imaging (MRI) - planned primarily surgical partial or complete repair by arthroscopic procedure - able to understand the content of the patient information/ consent form and give consent to take part in the project Exclusion Criteria: - surgical procedure for irreparable tears, i.e. muscle transfer, acromio-humeral spacer or superior capsular reconstruction - revision surgery (prior repair of the rotator cuff in the same shoulder) - planned open or mini-open reconstructions - patients with a language barrier hindering questionnaire completion (either in German, French, Italian or English) - patients unlikely to attend clinical follow-up - pregnancy - legal incompetence |
Country | Name | City | State |
---|---|---|---|
Germany | Department for Shoulder and Elbow surgery Center for Musculoskeletal Surgery Campus Virchow | Berlin | |
Switzerland | Kantonsspital Baden AG, | Baden | Aarau |
Switzerland | ARTHRO Medics AG | Basel | |
Switzerland | University Hospital Basel | Basel | |
Switzerland | Inselspital | Bern | |
Switzerland | Sonnenhof | Bern | |
Switzerland | Kantonsspital Baselland | Binningen | Baselland |
Switzerland | Hirslanden Clinique de Colline | Genève | |
Switzerland | University Hospital Geneva | Genève | |
Switzerland | Regional Hospital Lugano | Lugano | |
Switzerland | Hopital du Valois (RSV) | Martigny | Valais |
Switzerland | Hirslanden Klinik Birshof | Münchenstein | Baselland |
Switzerland | Bürgerspital Solothurn, Klinik für Orthopädie und Traumatologie | Solothurn | |
Switzerland | Klinik Gut | St Moritz | Graubünden |
Switzerland | Klinik tür Orthopädische Chirurgie und Traumatologie des Bewegungsapparates Kantonsspital St. Gallen | St. Gallen | Saint Gallen |
Switzerland | Zentrum für Orthopädie & Neurochirurgie In-Motion | Wallisellen | Zürich |
Switzerland | Kantonsspital Winterthur, Klinik für Orthopädie und Traumatologie | Winterthur | |
Switzerland | Endoclinic | Zürich | |
Switzerland | Schulthess Klinik | Zürich | |
Switzerland | Universitätsklinik Balgrist | Zürich |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland | Schweizerische Versicherungsanstalt (SUVA), Swiss National Science Foundation, Swiss Orthopaedics |
Germany, Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient-reported change in shoulder functional outcome OSS | The Oxford Shoulder Score (OSS) is a condition-specific questionnaire developed for patients with a degenerative or inflammatory state of the shoulder. It contains twelve items to be answered by the patient independently, which deal with pain (degree, time point) and possible handicaps in private and professional life.
There are five categories of response for every question, corresponding to a score ranging from 0 to 4. Scores are combined to give a single score, with a range from 0 (worst outcome) to 48 (best outcome). |
at Baseline and at 6 months after surgery. | |
Primary | Change of shoulder stiffness | this event was defined as a postoperative restriction in passive shoulder motion diagnosed within 6 months after ARCR in at least two of the motion planes of flexion, abduction and external rotation in 0° abduction. Motion restriction is to be assessed separately for each plane | at Baseline and at 6 months after surgery. | |
Secondary | Local AEs (Adverse events) according to the ARCR Core Event Set (CES) | Recurrent defect of repaired tendon(s) at 12 months: at least one repaired tendon is diagnosed with a recurrent defect by ultrasound examination.- Persistent or worsening pain
Infection Any local event |
24 months | |
Secondary | Constant Murley Score (CMS) | The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The scale is from 1 to 100 with higher scores indicating better outcome. | at 6 and 12 months | |
Secondary | Shoulder strength (kg) in abduction at 6 and 12 months | Highest possible Weight load of the Shoulder measured by dynamometer | at 6 and 12 months | |
Secondary | Change in Patient-reported shoulder pain on a Numeric Rating Scale (NRS) | The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults.
The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. A Higher Score means a worse outcome. The common format is a horizontal bar or line. Similar to the VAS, the NPRS is anchored by terms describing pain severity extremes. |
at 6, 12 months and 24 months | |
Secondary | Change in Oxford Shoulder Score (OSS) | The Oxford Shoulder Score (OSS) is a validated patient-reported outcome measure (PROM). It's a shoulder-specific instrument designed to assess the outcome of all shoulder surgeries (with the exception of instability surgery). The combined total gives a minimum score of 12 and a maximum of 60. Higher scores in the OSS imply worse functionality while lower scores imply better functionality. | at 6, 12 months and 24 months | |
Secondary | Subjective Shoulder Value (SSV) | The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% | at 6, 12 months and 24 months | |
Secondary | Nonrestorative sleep (NRS) to assess Patient-reported quality of sleep | Nonrestorative sleep (NRS) is defined as the subjective experience that sleep has not been sufficiently refreshing or restorative. On a scale from 0-10, 0 is best possible outcome measure and 10 is worst possible outcome measure. | at 6, 12 and 24 months | |
Secondary | Return to work, change of working condition | Return to work, change of working condition is measure in a standardized questionnaire noting among others absences | at 6, 12 and 24 months | |
Secondary | PROMIS Depression and Anxiety Short Formto assess level of depression and anxiety | Measured by Patient-Reported Outcomes Measurement Information System (PROMIS) scores. For PROMIS measures, higher scores equals more of the concept being measured. | at 6, 12 and 24 months | |
Secondary | Patient perceived shoulder functionality change, acceptability of own symptom state | Patient perceived shoulder functionality change, acceptability of own symptom state are measured with emphasis on minimally clinically important differences as stated in the cited literature with the according scored measurements | at 6, 12 and 24 months | |
Secondary | Quality of life (utilities and general health): EQ-5D-5L | Measured through EuroQoL version (EQ-5D-5L). The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. This tool has an overall health scale where the rater selects a number between 1-100 to describe the condition of their health, 1 being the worst and 100 being the best possible outcome. | at 12 and 24 months | |
Secondary | Adverse event (AE) assessment: AEs reported by clinicians and patients | AEs reported by clinicians and patients (including non-local AEs within 6 months after surgery) b. Final independent surgeon and patient-rated assessment of AEs according to perceived severity and relation to treatment (according to perceived severity (rating scale from 0 [no complication] to 100 [death] [67]) and disturbance) c. Comprehensive Complication Index (CCI) | 6 months | |
Secondary | Adverse event (AE) assessment: Final independent surgeon and patient-rated assessment of AEs | Final independent surgeon and patient-rated assessment of AEs according to perceived severity and relation to treatment (according to perceived severity (rating scale from 0 [no complication] to 100 [death]) and disturbance) | 6 months | |
Secondary | Adverse event (AE) assessment:Comprehensive Complication Index (CCI) | Comprehensive Complication Index (CCI): The Comprehensive Complication Index is based on the complication grading by Clavien-Dindo Classification and implements every occurred complication after an intervention. The overall morbidity is reflected on a scale from 0 (no complication) to 100 (death). | 6 months | |
Secondary | Rotator cuff and biceps tendon integrity by MRI | Postoperative integrity status of the rotator cuff classified by MRI | at 12 months | |
Secondary | Rotator cuff muscle fatty infiltration by MRI | Rotator cuff muscle fatty infiltration by MRI | at 12 months | |
Secondary | Status of repair implants e.g. anchors by MRI | Status of repair implants e.g. anchors by MRI | at 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03663036 -
Arthroscopic Superior Capsular Reconstruction With Fascia Lata Autograft - Survivorship of the Autograft Analysis
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Suspended |
NCT03290196 -
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
|
Phase 4 | |
Active, not recruiting |
NCT03091075 -
Oxandrolone Rotator Cuff Trial
|
N/A | |
Completed |
NCT03380533 -
Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair
|
Phase 2/Phase 3 | |
Completed |
NCT04566939 -
A Long Term Follow-Up of Rotator Cuff Tear Patients Treated With Integrated Complementary and Alternative Medicine
|
||
Active, not recruiting |
NCT02716441 -
Rotator Cuff Failure With Continuity
|
||
Completed |
NCT03540030 -
Opioid-Free Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT02298023 -
Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)
|
Phase 2 | |
Completed |
NCT02850211 -
A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair
|
Phase 4 | |
Completed |
NCT01459536 -
Assessment of Muscle Function and Size in Older Adults With Rotator Cuff Tear
|
N/A | |
Completed |
NCT01383239 -
Impact of Postoperative Management on Outcomes and Healing of Rotator Cuff Repairs
|
N/A | |
Completed |
NCT01170312 -
Arthroscopic Surgery and Platelet Rich Plasma In Rotator Cuff Tear Evaluation
|
N/A | |
Completed |
NCT01204606 -
Arthroscopic Rotator Cuff Repair With Multimodal Analgesia(MMA)
|
N/A | |
Terminated |
NCT00936559 -
Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair
|
Phase 1 | |
Completed |
NCT00852657 -
Comparison of Tendon Repair and Physiotherapy in the Treatment of Small and Medium-sized Tears of the Rotator Cuff
|
N/A | |
Active, not recruiting |
NCT00182299 -
An RCT to Compare the Outcomes of Patients With Large Rotator Cuff Repair That Undergo Repair With or Without SIS
|
Phase 4 | |
Recruiting |
NCT06120998 -
Quality of Life After Arthroscopic Rotator Cuff Repair
|
||
Completed |
NCT05897866 -
Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM)
|
N/A | |
Completed |
NCT02644564 -
Early Clinical Examination and Ultrasonography Screening of Acute Soft Tissue Shoulder Injuries
|
N/A |